期刊
DEVELOPMENTAL CELL
卷 49, 期 3, 页码 361-374出版社
CELL PRESS
DOI: 10.1016/j.devcel.2019.04.010
关键词
-
资金
- Brewster Foundation
- Breast Cancer Research Foundation
- Susan G. Komen Foundation
- Department of Defense
- National Institutes of Health
Epithelial-to-mesenchymal transition (EMT) and its reversed process, mesenchymal-to-epithelial transition (MET), are fundamental processes in embryonic development and tissue repair but confer malignant properties to carcinoma cells, including invasive behavior, cancer stem cell activity, and greater resistance to chemotherapy and immunotherapy. Understanding the molecular and cellular basis of EMT provides fundamental insights into the etiology of cancer and may, in the long run, lead to new therapeutic strategies. Here, we discuss the regulatory mechanisms and pathological roles of epithelial-mesenchymal plasticity, with a focus on recent insights into the complexity and dynamics of this phenomenon in cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据